Dr. Tejani received his Bachelor of Arts degree, Magna Cum Laude, from Amherst College in Amherst, Massachusetts. He later earned his medical degree from Dartmouth Medical School in Hanover, Hew Hampshire.

From 2004 to 2008, Dr.Tejani completed his residency and held the position of chief resident at Yale-New Haven Hospital in New Haven, Connecticut. Prior to joining
Wilmot Cancer Center, he was a fellow in hematology/oncology at Fox Chase Cancer Center/Temple University in Philadelphia, Pennsylvania.

Dr. Tejani is certified by the American Board of Internal Medicine and is licensed to practice medicine in the state of New York. He is a member of professional organizations including ASCO (American Society of Clinical Oncology) and AACR (American Association of Cancer Research).

In addition to being the recipient of several awards, Dr. Tejani has authored numerous oncology-related publications. Dr. Tejani's research experience and areas of interest include gastrointestinal cancers, head and neck cancer, communication and the culture of medicine. Dr. Tejani firmly believes that patient care is a privilege. Listening and responding to a patient's unique story is critical in helping that family on their cancer journey. Originally from Tanzania (East Africa), he is fluent in Swahili, Hindi, Urdu and Gujrati.

• Tejani MA, Burtness BA. Multi-Modality Therapy for Cancer of the Esophagus and GE Junction. Curr Treat Options Oncol. 2012 Sep; 13(3):390-402.
  View in: PubMed
• Tejani MA, Cohen RB, Mehra R. The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer. Biologics. 2010; 4:173-85.
  View in: PubMed
• Saif MW, Tejani MA. Safety of capecitabine use in patients with liver dysfunction. Clin Adv Hematol Oncol. 2007 Sep; 5(9):730-2; discussion 736.
  View in: PubMed